Navigation Links
Saladax Biomedical Announces Addition to Leadership Team

BETHLEHEM, Pa., July 22, 2013 /PRNewswire-iReach/ -- Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests with the goals of improving health and positively impacting the economics of care, today announced the hiring of John McAuliffe as Vice President of Companion Diagnostics Business Development. Mr. McAuliffe has over 20 years' experience in healthcare serving in roles including drug development, sales, marketing and business development. Prior to joining Saladax, Mr. McAuliffe contributed to the success of Athena Diagnostics during his 13 year tenure by serving in various roles up to and including Director of Business Development, Neurology where he was responsible for management of biomedical research as well as the identification, evaluation and launch of over 100 protein and molecular diagnostic assays, which led to acquisition by Quest Diagnostics from Thermo Fisher Scientific in 2011. Mr. McAuliffe is a member of the American Academy of Neurology, the American Society of Human Genetics, holds a Bachelor Degree of Science, Pharmacology, from the University of California Santa Barbara and has contributed to various peer reviewed scientific publications.

"Mr. McAuliffe is an excellent sales and business development professional with an undergraduate degree in pharmacology, background in pharmaceutical sales, experience in Companion Diagnostic deals, and is knowledgeable and published in the Alzheimer's space. His focus will primarily be to develop and manage business collaborations on the Companion Diagnostics side of our business." said Kevin Harter, President and CEO.

About Saladax Biomedical, Inc.

Saladax Biomedical is a leader in the development and deployment of high quality diagnostic services and products, delivering actionable data to help physicians to select and optimize the use of current and new pharmaceutical products, with the goals of improving health and positively impacting the economics of care. Saladax also serves as a valuable collaborator for pharmaceutical and biotechnology companies in the development of companion diagnostics (CDx), addressing multiple risks and challenges encountered in drug development.


Media Contact: Lorraine Damico, MBA, Saladax Biomedical Inc., 484-547-0529,

News distributed by PR Newswire iReach:

SOURCE Saladax Biomedical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
2. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
3. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
4. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
5. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
6. Live Press Briefing on Findings of Biomedical Industry CEO Survey
7. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
8. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
9. Minority Biomedical Entrepreneurship Conference
10. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
11. Fluke Biomedical training center goes global: adds multi-language support
Post Your Comments:
(Date:10/13/2015)... , Oct. 13 2015 Research and ... "US & Europe Markets for Bone Morphogenetic Protein ... to their offering. --> ... that induce the formation of bone after a fracture. ... embryonic development in the formation of the skeleton. There ...
(Date:10/13/2015)... FLORHAM PARK, N.J. and SAN ... Corporation (BASF) and Mast Therapeutics, Inc. have agreed to ... 188.  Currently, excipient-grade poloxamer 188 NF, marketed by BASF ... polymer used in a variety of pharmaceutical and biological ... production. Poloxamer 188 is the starting material for Mast,s ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... distributor of automation systems, material handling solutions and components, is opening its latest ... near State Street, the facility is Exotic’s second major expansion in Metropolitan Detroit ...
(Date:10/13/2015)... the United States , ... represents about 14% of all new cases of kidney cancer.   ... Canada and Europe .  PRCC represents ... --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces ... AB (publ) ("AstraZeneca") have completed enrolment in a global Phase II ...
Breaking Biology Technology:
(Date:9/30/2015)... -- With nearly 300,000 Americans living with spinal cord injuries ... reach 12,500 annually, the role of Independent Living Centers ... Living (SCRS-IL) is increasingly important. SCRS-IL is one ... opening doors to independence for individuals with SCIs by ... technology services and education. "In serving people ...
(Date:9/30/2015)...  The global glucose monitoring device and diabetes management market ... new report on the industry from Kalorama Information. Sales in the ... followed by continuous glucose monitoring and sensor segment, according to ... these products in its latest report, The Global Glucose ... , ...
(Date:9/29/2015)...  iDAvatars is excited to be named one of the ... The official announcement was recently made at an invite-only ... San Francisco , where iDAvatars presented a demo ... "It is both an honor and a privilege ... to market the cognitive power of IBM Watson in our ...
Breaking Biology News(10 mins):